Bridging Innovation for Health

Unified Access: Your single gateway to a full spectrum of assets, from APIs and intermediates to strategic licensing.

Products range from finished drugs (Rx/OTC), APIs, Intermediates, Excipients, to even licensing opportunities for clinical-stage novel drugs.

Our strategically located business centers across key continents form a powerful, integrated network.

The team has participated in the completion of 16 NDA/BLA and more than 100 IND applications for new drugs.

AI-powered analytics for market forecasting, candidate valuation, and risk assessment.

Our team members come from different countries with different cultural backgrounds.